Epidiolex as adjunct therapy for treatment of refractory epilepsy: a comprehensive review with a focus on adverse effects

@inproceedings{Sekar2019EpidiolexAA,
  title={Epidiolex as adjunct therapy for treatment of refractory epilepsy: a comprehensive review with a focus on adverse effects},
  author={Krithiga Sekar and Alison Pack},
  booktitle={F1000Research},
  year={2019}
}
Medically refractory epilepsy remains an area of intense clinical and scientific interest since a significant porportion of patients continue to suffer from debilitating seizures despite available therapies. In this setting, recent studies have focused on assessing the benefits of cannabidiol (CBD)-enriched cannabis, a plant based product without psychoactive properties which has been shown to decrease seizure frequency in animal models. More recently, several randomized controlled and open… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 29 REFERENCES

Similar Papers

Loading similar papers…